U.S. Army Captain Michael Kelvington, commander of the Battle company, 1-508 Parachute Infantry battalion, 4th Brigade Combat Team, 82nd Airborne Division, bows next to remains of Gulam Dostager, a member of Afghan Local Police who was killed in the blast of an Improvised Explosive Device (IED) during the joint Tor Janda (Black Flag in Pashtu) operation, in Zahri district of Kandahar province, southern Afghanistan May 25, 2012.  REUTERS/Shamil Zhumatov  (AFGHANISTAN - Tags: MILITARY CIVIL UNREST CONFLICT TPX IMAGES OF THE DAY)

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Members of the U.S. Navy Blue Angels fly over the World Trade Center in lower Manhattan as part of the 25th annual Fleet Week celebration in New York, May 23, 2012.  REUTERS/Eduardo Munoz (UNITED STATES - Tags: MILITARY ANNIVERSARY TPX IMAGES OF THE DAY)

Fleet Week

The U.S. Navy takes Manhattan for a week.  Slideshow 

Photo

The SpaceX mission

A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station.  Slideshow 

FACTBOX: Tuberculosis: A leading killer disease

Related Topics

HONG KONG | Tue Jan 5, 2010 7:14pm EST

HONG KONG (Reuters) - More than 2 billion people, or a third of the world's total population, are infected with Mycobacterium tuberculosis, the bacteria that causes tuberculosis.

Tuberculosis is the world's seventh-leading cause of death. It killed 1.8 million people worldwide last year, up from 1.77 million in 2007. It is one of three primary diseases that are closely linked to poverty, the other two being AIDS and malaria.

Here are some key facts about tuberculosis:

* Tuberculosis is spread easily through the air. When infectious people cough, sneeze, talk or spit, they expel the bacteria. Just a small amount is enough for transmission. Someone in the world is newly infected with TB every second.

* Nearly all TB infections are latent, with carriers showing no symptoms and they are not infectious. However, one in 10 will become sick with active TB in his or her lifetime due primarily to a weakened immune system.

* Of the 1.8 million deaths in 2008, or 4,930 deaths a day, half a million were AIDS patients. TB affects mostly young adults in their most productive years. The vast majority of TB deaths are in the developing world. More than half occur in Asia.

* The World Health Organization estimates that 9.4 million people developed active TB in 2008, up from 9.27 million in 2007 and 9.24 million in 2006. Among the 15 countries with the highest TB incidence rates in 2007, 13 were in Africa, while half of all new cases were in six Asian countries -- Bangladesh, China, India, Indonesia, Pakistan and the Philippines.

* TB is the seventh-highest cause of mortality in poor countries.

* The average TB patient loses three to four months of work and up to 30 percent of yearly household earnings. The World Bank estimates that the disease diminishes 4 percent to 7 percent of GDP in some of the worst-affected countries.

* Drug-resistant TB is caused by inconsistent or partial treatment often because patients stop taking their medication because they start to feel better.

* A particularly dangerous form of TB is multidrug-resistant TB (MDR-TB), which is TB that resists at least isoniazid and rifampicin, the two most powerful anti-TB drugs.

* Rates of MDR-TB are high in some countries, especially in India, China and the former Soviet Union, and threaten TB control efforts. MDR-TB is present in virtually all countries surveyed by the World Health Organization.

* Extensively drug-resistant TB, or XDR-TB, is a relatively rare type of TB. Between 35 percent and 50 percent of patients with this form of TB die.

Sources: WHO, U.S. Centers for Disease Prevention and Control, The Lancet series on Health System Reform in China, 2009. (Reporting by Tan Ee Lyn; Editing by Megan Goldin)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.